1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Stanford Community Symposium 2018: Ron Tompkins

Discussion in 'ME/CFS research news' started by NelliePledge, Sep 29, 2018.

  1. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    13,254
    Location:
    UK West Midlands
    This thread has been split from the Stanford Community Symposium 2018 thread.

    Ron Tompkins new Harvard based group have been engaging with U.K. biomedical researchers at Birmingham and Nottingham and are looking at putting in for MRC funding

    Didn’t catch names but I think they were on his slides.
     
    Last edited by a moderator: Oct 6, 2018
    Simon M, petrichor, MeSci and 7 others like this.
  2. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    13,254
    Location:
    UK West Midlands
    Did anyone catch any of the names of the UK researchers??
     
    ukxmrv, andypants and MEMarge like this.
  3. Binkie4

    Binkie4 Senior Member (Voting Rights)

    Messages:
    2,334


    https://www.omf.ngo/collaborative-research-center-harvard/

    Just had a google and names came up for both Nottingham and Birmingham researchers. See link above.

    Eta: bios of all the researchers provided. UK ones near the end of the list.
     
    NelliePledge, MeSci, Joh and 2 others like this.
  4. MEMarge

    MEMarge Senior Member (Voting Rights)

    Messages:
    2,746
    Location:
    UK
    Janet Lord, PhD, Professor of Immunology, University of Birmingham, and Chair of Immunology. Dr. Lord directs the Institute of Inflammation and Ageing and the MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research. Dr. Lord brings together fundamental scientists and clinicians to translate the understanding of inflammation to new treatments for chronic age-related inflammatory diseases. Her research focuses on the dysregulation of immunity in old age, and in particular, the decline in neutrophil function and how this compromises the response to infection and tissue injury. Her knowledge and leadership in the natural findings of inflammation upon tissues will be critical to understand many of the findings that are discovered in ME/CFS patients in this new initiative. She brings two essential colleagues to the new OMF Center, Drs. Paul Greenhaff and Philip Atherton.

    Paul Greenhaff, PhD, Professor of Muscle Metabolism, University of Nottingham, is a physiologist and the Deputy Director of the MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research (Nottingham). Dr. Greenhaff is also an active member of the ARUK Centre for Sport, Exercise and Osteoarthritis and the Musculoskeletal Disease theme of the Nottingham NIHR Biomedical Research Centre. He is classically trained in the field of muscle metabolism with research interests centered on the loss of muscle mass and the dysregulation of metabolism in aging, inactivity, inflammation, trauma and disease, and strategies to offset these pathophysiological events. His expertise will be critical to understand what the nutritional and sedentary effects are contributing to patients with ME/CFS in the new initiative.

    Philip Atherton, PhD, Professor of Clinical, Metabolic & Molecular Physiology, University of Nottingham is classically trained in stable isotope nutritional biochemistry, providing tremendous experience in the inflammation and metabolism fields. His laboratory is in the Royal Derby Hospital under the auspices of our UK Medical Research Council/Arthritis Research UK Centre of Excellence for musculoskeletal aging research and the newly awarded NIHR Biomedical Research Centre (BRC) under a clinical musculoskeletal theme. His research seeks identification of central mechanisms regulating metabolism in human musculoskeletal tissues. These interests and expertise will be critical to the new OMF Center.

    All 3 UK researchers seem to have experience with Arthritis UK- see above
     
    Sly Saint, Simon M, Sean and 10 others like this.
  5. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    13,254
    Location:
    UK West Midlands
    MEMarge, andypants and Binkie4 like this.
  6. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    13,254
    Location:
    UK West Midlands
    Really good to be getting more biomedical UK people involved in ME research.
     
    Sunshine3, MEMarge, inox and 3 others like this.
  7. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,582
    Location:
    UK
    OMF Conversations: ME/CFS patients and researchers connect

    https://www.youtube.com/watch?v=JW8YYJDSEdo




    transcript from Youtube
     

    Attached Files:

    ahimsa, Trish, Ravn and 6 others like this.
  8. MEMarge

    MEMarge Senior Member (Voting Rights)

    Messages:
    2,746
    Location:
    UK
    Looking forward to hearing Ron Tomkins speak at Invest in ME research conference in a couple of weeks
     
    andypants, Ravn, JaneL and 5 others like this.

Share This Page